GLP-1, 5mg/vial

Description

This vial contains a GLP-1 receptor agonist compound (5mg), supplied for laboratory research into incretin signaling and metabolic regulation pathways.

In laboratory research, GLP-1 receptor agonists are studied for their activity at the glucagon-like peptide-1 receptor, a class B G-protein-coupled receptor expressed in the pancreas, gastrointestinal tract, and central nervous system.

Researchers use GLP-1 receptor agonist compounds to investigate downstream signaling effects including glucose-dependent insulin secretion, delayed gastric emptying, and central appetite-related neural circuits, forming a core part of incretin pharmacology research.

The 5mg format supports researchers running dose-response or comparative pathway studies where a defined, consistent reagent quantity is required across experimental replicates.

This compound is supplied strictly for laboratory research purposes into GLP-1 receptor pharmacology and metabolic signaling.